Group 1 - The core point of the article is that the HPV vaccine has been included in the national immunization program in China, with the domestically developed nine-valent HPV vaccine officially in use [1] - The National Health Commission announced that HPV vaccination services will be provided for eligible girls this year, enhancing the accessibility and affordability of HPV vaccines in China [1] - The nine-valent HPV vaccine developed by Wantai Biological Pharmacy has been approved for market launch, making it the first domestically produced nine-valent HPV vaccine in China and the second globally [1] Group 2 - The price of the domestically produced nine-valent HPV vaccine is set at 499 yuan per dose, which is approximately 40% of the price of imported similar products [2] - For females aged 9 to 17, a two-dose vaccination schedule costs a total of 998 yuan, while for those aged 18 to 45, a three-dose schedule costs about 1500 yuan [2]

Group 1 - Guangzhou has initiated HPV vaccination programs across multiple districts, including Panyu, Tianhe, Yuexiu, Haizhu, Zengcheng, Huadu, and Baiyun, with no restrictions on residency or household registration [1] - The vaccination campaign aims to establish a comprehensive prevention system covering adolescents, adult women, and men, encouraging early vaccination for better protection against cervical cancer [1] - Experts emphasize the importance of HPV vaccination for both genders, as HPV infection poses health risks to men and women alike, and early vaccination can help prevent the spread of the virus [2][3] Group 2 - The majority of cervical cancer cases are linked to persistent high-risk HPV infections, with recommendations for girls aged 9 to 14 being the primary target group for vaccination [2] - There is a growing trend of HPV infections among younger populations, highlighting the need for early vaccination to maximize benefits [2] - The nine-valent HPV vaccine has been used in 112 countries, accumulating extensive real-world data, allowing individuals to choose from different types of HPV vaccines based on their health needs [3]

Core Points - The Guangxi Health Commission, along with other departments, has launched a free HPV vaccination program for eligible girls in Guangxi, aiming to vaccinate nearly 960,000 girls from 2025 to 2027 [1] - The program targets middle school girls aged 13 to under 14 who have not previously received the HPV vaccine, ensuring a comprehensive vaccination coverage across urban and rural areas [1][2] - The vaccination information will be integrated into the immunization planning information system to ensure traceability and control over the vaccination process [1] Group 1 - The HPV vaccine is crucial in preventing cervical and anal cancers, with the best protection achieved when administered before the onset of sexual activity [2] - Since 2021, the Guangxi Women's Federation has raised 7.8 million yuan to support the "Accelerate the Elimination of Cervical Cancer Action Plan," providing free vaccinations to 7,483 women [2] - The free vaccination policy has been expanded to cover all eligible girls in both urban and rural areas, with significant support from local representatives [2]

Core Points - The article discusses the launch of a free HPV vaccination program for eligible girls in Hangzhou, Zhejiang Province, as part of a key public health initiative for 2025 [1] - HPV is a common virus that can lead to serious health issues, including cervical cancer, with 90% of cervical cancer cases linked to HPV infection [1] - The program targets girls aged 13-14, aligning with WHO recommendations for optimal vaccination timing [1][2] Group 1: Vaccination Program Details - The vaccination is specifically for girls with Zhejiang Province residency or school enrollment [2] - Eligible girls must be aged 13-14 and should not have any prior HPV vaccinations [2] - The program offers the domestic bivalent HPV vaccine, with a recommended two-dose schedule [3] Group 2: Vaccination Guidelines - The vaccination schedule suggests administering doses at 0 and 6 months, with a minimum interval of 5 months [3] - Certain health conditions, such as fever or acute diseases, may require postponement of vaccination [3] - Parents and guardians are encouraged to consult local health authorities for specific vaccination information [3]

Group 1 - The core viewpoint of the article highlights the launch of the free vaccination program for the bivalent HPV vaccine for girls aged 13-14 in Hangzhou, which has been part of the municipal government's livelihood projects for two consecutive years [1][2] - Since the program's initiation in 2024, over 10,000 eligible girls have been vaccinated, with more than 600 girls in the Qingshan District having received their first dose [1] - The vaccination aims to build a health defense against HPV, which is linked to various cancers, particularly cervical cancer, with 90% of cases caused by HPV infection [1] Group 2 - The World Health Organization recommends girls aged 9-14 as the primary target group for HPV vaccination due to their ability to develop higher immunity at a younger age [2] - The vaccination program is open to girls with Zhejiang province residency or school enrollment, who have not previously received the HPV vaccine, and consists of two doses administered at least five months apart [2] - Precautions are advised for those with fever, acute diseases, or chronic disease flare-ups, who should postpone or avoid vaccination [2]